In lung cancer, serum levels of soluble CRIPTO were identified as a diagnostic and prognostic marker, whereas CRIPTO expression in tumor tissues was associated with worse prognosis (16, 25–30). The gene discussed is CRIPTO; the disease is lung cancer.